Condition
HBV Related Acute-on-chronic Liver Failure
Total Trials
3
Recruiting
2
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Recruiting2
Active Not Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07275554RecruitingPrimary
Analysis of Methylomic Features and Prognostic Risk Prediction in Patients With Hepatitis B-related Acute-on-chronic Liver Failure
NCT06865898Active Not RecruitingPrimary
Plasma Proteomics Study of End-Stage Liver Disease Patients Based on Olink Technology
NCT06865859RecruitingPrimary
Single Cell Landscape of HBV-related Acute-on-chronic Liver Failure Patients
Showing all 3 trials